Patent · US Active

Anti-VEGF antibodies

US8975381B2 · kind B2 · utility

5Cited by
27References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 2013
Grant dateMar 10, 2015
Priority date
Expiry dateJun 27, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.